Today's Daily Dose brings you news about the fund received by Cyclerion from Alzheimer's Association, Immunovant's myasthenia gravis trial meeting key goals, MediWound's first shipment of NexoBrid to BARDA, Ovid's ELEKTRA study results and Sarepta's regulatory catalyst.
from RTT - Biotech https://ift.tt/32ldXPi
via IFTTT
No comments:
Post a Comment